GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » ROA %

Stella Pharma (TSE:4888) ROA % : -16.23% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Stella Pharma ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Stella Pharma's annualized Net Income for the quarter that ended in Dec. 2023 was 円-654.8 Mil. Stella Pharma's average Total Assets over the quarter that ended in Dec. 2023 was 円4,034.3 Mil. Therefore, Stella Pharma's annualized ROA % for the quarter that ended in Dec. 2023 was -16.23%.

The historical rank and industry rank for Stella Pharma's ROA % or its related term are showing as below:

TSE:4888' s ROA % Range Over the Past 10 Years
Min: -30.68   Med: -23.72   Max: -17.22
Current: -18.53

During the past 5 years, Stella Pharma's highest ROA % was -17.22%. The lowest was -30.68%. And the median was -23.72%.

TSE:4888's ROA % is ranked better than
66.45% of 1550 companies
in the Biotechnology industry
Industry Median: -35.055 vs TSE:4888: -18.53

Stella Pharma ROA % Historical Data

The historical data trend for Stella Pharma's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Pharma ROA % Chart

Stella Pharma Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23
ROA %
-23.72 -30.68 -28.00 -22.69 -17.22

Stella Pharma Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.23 -28.21 -15.55 -13.45 -16.23

Competitive Comparison of Stella Pharma's ROA %

For the Biotechnology subindustry, Stella Pharma's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stella Pharma's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stella Pharma's ROA % distribution charts can be found below:

* The bar in red indicates where Stella Pharma's ROA % falls into.



Stella Pharma ROA % Calculation

Stella Pharma's annualized ROA % for the fiscal year that ended in Mar. 2023 is calculated as:

ROA %=Net Income (A: Mar. 2023 )/( (Total Assets (A: Mar. 2022 )+Total Assets (A: Mar. 2023 ))/ count )
=-778.824/( (4718.649+4329.053)/ 2 )
=-778.824/4523.851
=-17.22 %

Stella Pharma's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-654.82/( (4141.782+3926.718)/ 2 )
=-654.82/4034.25
=-16.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


Stella Pharma  (TSE:4888) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-654.82/4034.25
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-654.82 / 184.792)*(184.792 / 4034.25)
=Net Margin %*Asset Turnover
=-354.36 %*0.0458
=-16.23 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Stella Pharma ROA % Related Terms

Thank you for viewing the detailed overview of Stella Pharma's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Pharma (TSE:4888) Business Description

Traded in Other Exchanges
N/A
Address
3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.

Stella Pharma (TSE:4888) Headlines

No Headlines